Core Insights - The 67th American Society for Radiation Oncology (ASTRO) annual meeting showcased ZAP Surgical's ZAP-X, a cutting-edge robotic system for precise brain tumor radiation therapy, highlighting its technological advancements and clinical results [1][2] - A peer-reviewed study presented at the conference revealed significant differences in low-dose radiation spillover to healthy brain tissue across different platforms, with ZAP-X offering superior protection compared to traditional devices [1][2] Company Overview - ZAP-X is designed to optimize precision radiation therapy for brain tumors, utilizing a unique dual-rotating spherical structure that allows for thousands of non-coplanar beams, resulting in higher target doses and lower exposure to surrounding healthy tissue [2] - The system features sub-millimeter precision, real-time dose imaging, and ultra-low leakage, setting a new benchmark in safety and accuracy for radiation surgery [2] Market Position - ZAP-X has received market approval in 24 countries and regions, with over 70 global clients and more than 5,000 clinical treatments completed [2] - The company is focused on advancing the localization of ZAP-X manufacturing in China, with a new high-end manufacturing base in Beijing set to become the global production hub [2]